155 related articles for article (PubMed ID: 35565243)
1. Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial.
Ozaki A; Kessoku T; Tanaka K; Yamamoto A; Takahashi K; Takeda Y; Kasai Y; Iwaki M; Kobayashi T; Yoshihara T; Kato T; Suzuki A; Honda Y; Ogawa Y; Fuyuki A; Imajo K; Higurashi T; Yoneda M; Taguri M; Ishiki H; Kobayashi N; Saito S; Ichikawa Y; Nakajima A
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565243
[TBL] [Abstract][Full Text] [Related]
2. Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study.
Ozaki A; Kessoku T; Iwaki M; Kobayashi T; Yoshihara T; Kato T; Honda Y; Ogawa Y; Imajo K; Higurashi T; Yoneda M; Taguri M; Yamanaka T; Ishiki H; Kobayashi N; Saito S; Ichikawa Y; Nakajima A
Trials; 2020 Jun; 21(1):453. PubMed ID: 32487150
[TBL] [Abstract][Full Text] [Related]
3. Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer.
Katakami N; Harada T; Murata T; Shinozaki K; Tsutsumi M; Yokota T; Arai M; Tada Y; Narabayashi M; Boku N
Ann Oncol; 2018 Jun; 29(6):1461-1467. PubMed ID: 32151367
[TBL] [Abstract][Full Text] [Related]
4. Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives.
Hale ME; Wild JE; Yamada T; Yokota T; Tack J; Andresen V; Drewes AM
Therap Adv Gastroenterol; 2021; 14():17562848211032320. PubMed ID: 34377150
[TBL] [Abstract][Full Text] [Related]
5. Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies.
Saito Y; Yokota T; Arai M; Tada Y; Sumitani M
J Pain Res; 2019; 12():127-138. PubMed ID: 30613161
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Double-blind Placebo-controlled Trial on the Effect of Magnesium Oxide in Patients With Chronic Constipation.
Mori S; Tomita T; Fujimura K; Asano H; Ogawa T; Yamasaki T; Kondo T; Kono T; Tozawa K; Oshima T; Fukui H; Kimura T; Watari J; Miwa H
J Neurogastroenterol Motil; 2019 Oct; 25(4):563-575. PubMed ID: 31587548
[TBL] [Abstract][Full Text] [Related]
7. Translating Clinical Findings into the Patient's Perspective: Post-hoc Pooled Analysis of Bowel Movement Changes as a Predictor of Improvement in Patients' Opioid-induced Constipation Symptoms and Outcomes.
Coyne KS; Poon JL; Thompson C; Hu Y; Datto CJ; Sostek M
Clin Ther; 2017 Jan; 39(1):75-88. PubMed ID: 27938897
[TBL] [Abstract][Full Text] [Related]
8. A Renal Impairment Subgroup Analysis of the Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy.
Webster LR; Hale ME; Yamada T; Wild JE
J Pain Res; 2020; 13():605-612. PubMed ID: 32280263
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol.
Higashibata T; Hamano J; Kessoku T; Kajiura S; Hirakawa M; Horie Y; Shimizu M; Oyamada S; Ariyoshi K; Kihara K; Yamanaka Y; Konishi K; Doki K; Takashima Y; Horiuchi M; Homma M; Yamada T; Yamamoto Y; Moriwaki T; Morita T; Nakajima A; Nagaoka H
Contemp Clin Trials Commun; 2022 Oct; 29():100967. PubMed ID: 35967517
[TBL] [Abstract][Full Text] [Related]
10. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial.
Morishita D; Tomita T; Mori S; Kimura T; Oshima T; Fukui H; Miwa H
Am J Gastroenterol; 2021 Jan; 116(1):152-161. PubMed ID: 32969946
[TBL] [Abstract][Full Text] [Related]
11. Effects of Electroacupuncture on Opioid-Induced Constipation in Patients With Cancer: Study Protocol for a Multicenter Randomized Controlled Trial.
Wang W; Wang X; Liu Y; Sun Y; Liu X; Yan Y; Liu Z
Front Med (Lausanne); 2022; 9():818258. PubMed ID: 35492306
[TBL] [Abstract][Full Text] [Related]
12. Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies.
Camilleri M; Hale M; Morlion B; Tack J; Webster L; Wild J
J Pain Res; 2021; 14():2179-2189. PubMed ID: 34295186
[TBL] [Abstract][Full Text] [Related]
13. Update on the role of naldemedine in opioid-induced constipation in patients with chronic noncancer pain.
BouSaba J; Sannaa W; Camilleri M
Therap Adv Gastroenterol; 2022; 15():17562848221078638. PubMed ID: 35509419
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Naloxegol in Patients with Chronic Non-Cancer Pain Who Experience Opioid-Induced Constipation: A Pooled Analysis of Two Global, Randomized Controlled Studies.
Chey WD; Brenner DM; Cash BD; Hale M; Adler J; Jamindar MS; Rockett CB; Almenoff JS; Bortey E; Gudin J
J Pain Res; 2023; 16():2943-2953. PubMed ID: 37664485
[TBL] [Abstract][Full Text] [Related]
15. Naldemedine and Magnesium Oxide as First-Line Medications for Opioid-Induced Constipation: A Comparative Database Study in Japanese Patients With Cancer Pain.
Kessoku T; Higashibata T; Morioka Y; Naya N; Koretaka Y; Ichikawa Y; Hisanaga T; Nakajima A
Cureus; 2024 Mar; 16(3):e55925. PubMed ID: 38601408
[TBL] [Abstract][Full Text] [Related]
16. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer.
Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A
J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the efficacy and safety of electro-acupuncture in patients with antipsychotic-related constipation: protocol for a randomized controlled trial.
Yu FT; Long DH; Shi GX; Wang LQ; Tu JF; Gang LL; Liu FQ; Wang Y; Cui X; Bao S; Yu Y; Wei W; Yan SY; Yang JW; Liu CZ
Trials; 2021 Nov; 22(1):771. PubMed ID: 34736504
[TBL] [Abstract][Full Text] [Related]
18. Opioid therapy duration before naldemedine treatment is a significant independent risk of diarrhea: a retrospective cohort study.
Okamoto A; Ikemura K; Mizutani E; Iwamoto T; Okuda M
J Pharm Health Care Sci; 2021 Feb; 7(1):3. PubMed ID: 33517900
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy Survey of Naldemedine in the Poor-performance Status Group].
Kato S; Saito Y; Onoda H; Kumai M; Imai S; Tsuruga K; Takekuma Y; Sugawara M
Yakugaku Zasshi; 2022; 142(7):755-760. PubMed ID: 35781505
[TBL] [Abstract][Full Text] [Related]
20. [Post-stroke constipation treated with acupoint embedding therapy: a multi-center randomized controlled trial].
Du J; Liu H; Xu J; Lu CM; Zhou JF; Wu PH; Zheng LY; Li XW
Zhongguo Zhen Jiu; 2020 May; 40(5):493-7. PubMed ID: 32394656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
